IDYA · IDEAYA Biosciences
AI read · Good for IDYA
The AI's read
This gives IDEAYA another possible treatment program to study alone or with other drugs. The target is found in about 10% to 15% of solid tumors, including about 70% of pancreatic ductal adenocarcinoma. But studies are still underway before testing in people, and the filing is planned for 2027, so patient benefit remains unproven.